Fertility-sparing management of gynecological cancers

Maturitas

Volumn 82, Issue 2, 2015, Pages 141-145

  Fastrez, M ^a   Houba, C ^a   Vandromme, J ^a   Rozenberg, S ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Fertility; Gynecological malignancies; Treatment

Indexed keywords

CANCER PROGNOSIS; CONSERVATIVE TREATMENT; ENDOMETRIUM CANCER; FEMALE; FEMALE FERTILITY; FEMALE GENITAL TRACT CANCER; GERM CELL TUMOR; HEALTH CARE QUALITY; HUMAN; MALIGNANT OVARIAN GERM CELL TUMOR; OBSTETRIC OPERATION; OVARY CANCER; OVARY CARCINOMA; PATIENT SELECTION; REVIEW; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; FERTILITY PRESERVATION; GENITAL NEOPLASMS, FEMALE; PREGNANCY; PROCEDURES;

FEMALE; FERTILITY PRESERVATION; GENITAL NEOPLASMS, FEMALE; HUMANS; PREGNANCY;

EID: 84942817823     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2015.06.031     Document Type: Review

References (36)

1. T.J. Matthews, and B.E. Hamilton Delayed childbearing: more women are having their first child later in life NCHS Data Brief 2009 1 8
2. A. Makar, and C. Tropé Fertility preservation in gynecologic cancer Acta Obstet. Gynecol. Scand. 80 2001 794 802
3. E. Leblanc, F. Narducci, G. Ferron, and D. Querleu Indications and teaching of fertility preservation in the surgical management of gynecologic malignancies: European perspective Gynecol. Oncol. 114 Suppl 2 (Aug) 2009 S32 S36
4. P.A. Lloyd, E.V. Briggs, N. Kane, A.R. Jeyarajah, and J.H. Shepherd Women's experiences after a radical vaginal trachelectomy for early stage cervical cancer. A descriptive phenomenological study Eur. J. Oncol. Nurs. 18 4 (Aug) 2014 362 371
5. P. Benedetti-Panici, F. Maneschi, G. D'Andrea, and et al. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study Cancer 88 2000 2267 2274
6. E. Diakomanolis, D. Haidopoulos, A. Rodolakis, and et al. Laser CO(2) conization: a safe mode of treating conservatively microinvasive carcinoma of the uterine cervix Eur. J. Obstet. Gynecol. Reprod. Biol. 113 2004 229 233
7. M. McHale, T. Le, R. Burger, M. Gu, J. Rutgers, and B. Monk Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix Obstet. Gynecol. 98 Pt 1 2001 726 731
8. K. Bisseling, R. Bekkers, R. Rome, and M. Quinn Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature Gynecol. Oncol. 107 2007 424 430
9. M. Kyrgiou, G. Koliopoulos, P. Martin-Hirsch, M. Arbyn, W. Prendiville, and E. Paraskevaidis Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis Lancet 367 2006 489 498
10. C. Werner, J. Lo, T. Heffernan, W. Griffith, D. McIntire, and K. Leveno Loop electrosurgical excision procedure and risk of preterm birth Obstet. Gynecol. 115 2010 605 608
11. A. Covens, B. Rosen, J. Murphy, S. Laframboise, A.D. DePetrillo, G. Lickrish, and et al. How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol. Oncol. 84 2002 145 149
12. R.N. Eskander, L.M. Randall, M.L. Berman, K.S. Tewari, P.J. Disaia, and R.E. Bristow Fertility preserving options in patients with gynecologic malignancies Am. J. Obstet. Gynecol. 205 2 (Aug) 2011 103 110
13. P. Marchiole, M. Benchaib, A. Buenerd, E. Lazlo, D. Dargent, and P. Mathevet Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent's operation): a comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH) Gynecol. Oncol. 106 2007 132 141
14. L. Gien, and A. Covens Fertility-sparing options for early stage cervical cancer Gynecol. Oncol. 117 2010 350 357
15. M. Plante Vaginal radical trachelectomy: an update Gynecol. Oncol. 111 2008 S105 S110
16. P.T. Ramirez, R. Pareja, G.J. Rendón, C. Millan, M. Frumovitz, and K.M. Schmeler Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care? Gynecol. Oncol. 132 1 (Jan) 2014 254 259
17. M. Plante, S. Lau, L. Brydon, K. Swenerton, R. LeBlanc, and M. Roy Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: case report Gynecol. Oncol. 101 2 (May) 2006 367 370
18. A. Maneo, S. Chiari, C. Bonazzi, and C. Mangioni Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer Gynecol. Oncol. 111 3 (Dec) 2008 438 443
19. P. Marchiole, J.D. Tigaud, S. Costantini, S. Mammoliti, A. Buenerd, E. Moran, and P. Mathevet Neoadjuvant chemotherapy and vaginal radical trachelectomy for fertility-sparing treatment in women affected by cervical cancer (FIGO stage IB-IIA1) Gynecol. Oncol. 122 3 (Sep) 2011 484 490
20. H. Robova, M.J. Halaska, M. Pluta, P. Skapa, J. Matecha, J. Lisy, and L. Rob Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer Gynecol. Oncol. 135 2 (Nov) 2014 213 216
21. Office for National Statistics Cancer Statistics Registrations: Registrations of Cancer Diagnosed in 2007 2010 National Statistics England, London, United Kingdom (Series MB1 no. 38)
22. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J. Clin. 60 2010 277 300
23. I.D. Gallos, J. Yap, M. Rajkhowa, D.M. Luesley, A. Coomarasamy, and J.K. Gupta Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and meta-analysis Am. J. Obstet. Gynecol. 207 4 (Oct) 2012 266 2712
24. I. Skirnisdottir, H. Garmo, E. Wilander, and L. Holmberg Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer Int. J. Cancer 123 2008 1897 1901
25. E. Daraï, R. Fauvet, C. Uzan, S. Gouy, P. Duvillard, and P. Morice Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options Hum. Reprod. Update 19 2 (Mar-Apr) 2013 151 166
26. S. Palomba, E. Zupi, T. Russo, A. Falbo, S. Del Negro, F. Manguso, D. Marconi, A. Tolino, and F. Zullo Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study Hum. Reprod. 22 2007 578 585
27. S. Palomba, A. Falbo, S. Del Negro, M. Rocca, T. Russo, F. Cariati, G. Annunziata, A. Tolino, P. Tagliaferri, and F. Zullo Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up Hum. Reprod. 25 2010 1966 1972
28. G. Zanetta, S. Rota, S. Chiari, C. Bonazzi, G. Bratina, and C. Mangioni Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study J. Clin. Oncol. 19 2001 2658 2664
29. C. Uzan, A. Kane, A. Rey, S. Gouy, P. Duvillard, and P. Morice Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary Ann. Oncol. 21 2010 55 60
30. I. Vasconcelos, and M. de Sousa Mendes Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk Eur. J. Cancer 51 5 (Mar) 2015 620 631
31. N. Murugaesu, P. Schmid, G. Dancey, and et al. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment J. Clin. Oncol. 24 2006 4862 4866
32. D.M. Gershenson Management of ovarian germ cell tumors J. Clin. Oncol. 25 2007 2938 2943
33. O. Solheim, J. Kærn, C.G. Tropé, and et al. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009) Gynecol. Oncol. 131 11 2013 330 335
34. D. Matei, J. Brown, and L. Frazier Updatesinthemanagementofovariangermcelltumors Am. Soc. Clin. Oncol. Educ. Book 2013 2013 210 216
35. C. Parkinson, H. Hatcher, and H. Earl Multidisciplinary management of malignant ovarian germ cell tumors Gynecol. Oncol. 121 2011 625 636
36. O. Solheim, C.G. Tropé, E. Rokkones, J. Kærn, T. Paulsen, H.B. Salvesen, B. Hagen, A.B. Vereide, and S.D. Fosså Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the cisplatin era Gynecol. Oncol. 136 2 (Feb) 2015 224 229